-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Maravai Lifesciences Holdings, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q1 2024.
- Maravai Lifesciences Holdings, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
- Maravai Lifesciences Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $755M, a 1684% increase from 2022.
- Maravai Lifesciences Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $42.3M, a 9.78% decline from 2021.
- Maravai Lifesciences Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $46.9M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)